secwatch / observer
8-K filed February 3, 2022, 6:59 PM ET ticker GSHD CIK 0001726978
other material confidence high sentiment neutral materiality 0.30

Goosehead appoints two new independent directors to board; committee changes

Goosehead Insurance, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Thomas McConnon

Director
GSHD · Goosehead Insurance, Inc.
Effective
2022-02-02
Filed
February 3, 2022, 6:59 PM ET
On February 2, 2022, Thomas McConnon and Waded Cruzado were each appointed to Goosehead Insurance, Inc.’s (the “Company”) Board of Directors (the “Board”).
Appointed

Waded Cruzado

Director
GSHD · Goosehead Insurance, Inc.
Effective
2022-02-02
Filed
February 3, 2022, 6:59 PM ET
On February 2, 2022, Thomas McConnon and Waded Cruzado were each appointed to Goosehead Insurance, Inc.’s (the “Company”) Board of Directors (the “Board”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas McConnon was appointed as Director at Goosehead Insurance, Inc..

Action
appointed
Role
Director
Exact text from the filing
On February 2, 2022, Thomas McConnon and Waded Cruzado were each appointed to Goosehead Insurance, Inc.’s (the “Company”) Board of Directors (the “Board”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Waded Cruzado was appointed as Director at Goosehead Insurance, Inc..

Action
appointed
Role
Director
Exact text from the filing
On February 2, 2022, Thomas McConnon and Waded Cruzado were each appointed to Goosehead Insurance, Inc.’s (the “Company”) Board of Directors (the “Board”).
View on SEC.gov

Goosehead Insurance, Inc. filing history →

Source: SEC EDGAR
accession 0001726978-22-000013
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.